ACCENDRA HEALTH INC/VA/ Financial Summary

Quick Answer

ACCENDRA HEALTH INC/VA/ reported Total Revenue of $2.76 billion for fiscal year 2025.

ACCENDRA HEALTH INC/VA/ — Key Financials by Year

Metric 2025 2024 2023 2022 2021 2020
Total Revenue $2.76B
+3.1%
$2.68B
+5.0%
$2.55B
-74.4%
$9.96B
+1.7%
$9.79B
+15.4%
$8.48B
-7.9%
Revenue (ASC 606) $2.76B
+3.1%
$2.68B
+5.0%
$2.55B
-74.4%
$9.96B
+1.7%
$9.79B
+15.4%
$8.48B
-7.9%
Net Income -$1.10B
-203.5%
-$362.69M
-778.2%
-$41.30M
-284.5%
$22.39M
-89.9%
$221.59M
+641.8%
$29.87M
+147.9%
Diluted EPS -$14.31
-202.5%
-$4.73
-792.5%
-$0.53
-282.8%
$0.29
-90.1%
$2.94
+525.5%
$0.47
+145.6%
Total Assets $2.45B
-47.3%
$4.66B
-8.6%
$5.09B
-5.4%
$5.39B
+52.3%
$3.54B
+6.0%
$3.34B
-8.4%
Cash and Equivalents $281.99M
+922.7%
$27.57M
-88.7%
$243.04M
+249.9%
$69.47M
+24.7%
$55.71M
-32.9%
$83.06M
+23.9%
Stockholders Equity -$460.98M
-178.6%
$586.36M
-38.0%
$945.30M
-2.2%
$966.74M
+3.0%
$938.50M
+31.8%
$712.05M
+54.1%
Operating Income $27.46M
+112.6%
-$217.73M
-263.4%
$133.23M
-6.8%
$142.91M
-61.2%
$368.47M
+80.5%
$204.12M
+179.0%
Gross Profit $2.22B
+4.4%
$2.13B
+16.4%
$1.83B
+20.7%
$1.51B
+18.1%
$1.28B
+13.5%
Shares Outstanding 76.39M
-1.1%
77.20M
+0.9%
76.55M
+0.4%
76.28M
+1.1%
75.43M
+2.7%
73.47M
+16.9%

Most Recent Quarter

Metric Quarter Ending Value YoY QoQ
Total Revenue September 30, 2025 $697.26M +1.5% +2.3%
Revenue (ASC 606) September 30, 2025 $697.26M +1.5% +2.3%
Net Income September 30, 2025 -$150.28M -1076.8% +82.7%
Diluted EPS September 30, 2025 -$1.94 -1112.5% +82.8%
Total Assets September 30, 2025 $4.04B -20.6% -2.8%
Cash and Equivalents September 30, 2025 $32.84M -27.8% -14.2%
Stockholders Equity September 30, 2025 -$429.51M -148.0% -52.8%
Operating Income September 30, 2025 $26.47M -14.8% +166.7%
Gross Profit March 31, 2025 $526.01M -1.8% -6.0%
Shares Outstanding September 30, 2025 77.30M +0.3% +0.1%
  • ACCENDRA HEALTH INC/VA/ reported Total Revenue of $2.76 billion for fiscal year 2025.
  • ACCENDRA HEALTH INC/VA/ showed an increase of +3.1% in Total Revenue compared to the prior fiscal year.
  • ACCENDRA HEALTH INC/VA/ reported Revenue (ASC 606) of $2.76 billion for fiscal year 2025.
  • ACCENDRA HEALTH INC/VA/ showed an increase of +3.1% in Revenue (ASC 606) compared to the prior fiscal year.
  • ACCENDRA HEALTH INC/VA/ reported Net Income of -$1.10 billion for fiscal year 2025.
  • ACCENDRA HEALTH INC/VA/ showed a decrease of -203.5% in Net Income compared to the prior fiscal year.
  • ACCENDRA HEALTH INC/VA/ reported Diluted EPS of $14.31 per share (loss) for fiscal year 2025.
  • ACCENDRA HEALTH INC/VA/ showed a decrease of -202.5% in Diluted EPS compared to the prior fiscal year.
  • ACCENDRA HEALTH INC/VA/ reported Total Assets of $2.45 billion for fiscal year 2025.
  • ACCENDRA HEALTH INC/VA/ showed a decrease of -47.3% in Total Assets compared to the prior fiscal year.
  • ACCENDRA HEALTH INC/VA/ reported Cash and Equivalents of $281.99 million for fiscal year 2025.
  • ACCENDRA HEALTH INC/VA/ showed an increase of +922.7% in Cash and Equivalents compared to the prior fiscal year.
  • ACCENDRA HEALTH INC/VA/ reported Stockholders Equity of -$460.98 million for fiscal year 2025.
  • ACCENDRA HEALTH INC/VA/ showed a decrease of -178.6% in Stockholders Equity compared to the prior fiscal year.
  • ACCENDRA HEALTH INC/VA/ reported Operating Income of $27.46 million for fiscal year 2025.
  • ACCENDRA HEALTH INC/VA/ showed an increase of +112.6% in Operating Income compared to the prior fiscal year.
  • ACCENDRA HEALTH INC/VA/ reported Gross Profit of $2.22 billion for fiscal year 2024.
  • ACCENDRA HEALTH INC/VA/ showed an increase of +4.4% in Gross Profit compared to the prior fiscal year.
  • ACCENDRA HEALTH INC/VA/ reported Shares Outstanding of 76.39 million shares for fiscal year 2025.
  • ACCENDRA HEALTH INC/VA/ showed a decrease of -1.1% in Shares Outstanding compared to the prior fiscal year.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment